Clinical Trial Update: Cemiplimab for the Treatment of Incurable Metastatic or Unresectable NUT Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for cemiplimab in incurable metastatic or unresectable NUT carcinoma; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nut Carcinoma

Drugs mentioned

• Cemiplimab (cemiplimab)

Snippet

Sponsor: Northwestern University | Conditions: Metastatic NUT Carcinoma, Unresectable NUT Carcinoma | Phase 2 | Status: RECRUITING